Skip to main content

Nonprofit · EIN 95-4310830

CELIAC DISEASE FOUNDATION

Tax-exempt · WOODLAND HLS, CA 91367

Financials

$4.2M$3M2023$4.3M$4.3M2024$5.3M$4.6M2025
Revenue Expenses · by fiscal year end
Financials of CELIAC DISEASE FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$5,315,881$4,579,989$735,892$8,297,238$1,467,942$6,829,296
December 31, 2024990 (amended)$4,294,353$4,336,074-$41,721$7,559,145$2,000,126$5,559,019
December 31, 2023990 (amended)$4,203,443$2,975,235$1,228,208$5,959,854$633,790$5,326,064
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$2,568,848
Program service revenue
$2,389,372
Investment income
$149,308
Net gain from sales of assets
-$2,912
Net income from fundraising events
$208,353
Other revenue
$208,353

Expenses

Grants and similar amounts paid
$355,540
Compensation of officers, directors and key employees
$760,428
Other salaries and wages
$1,325,936
Salaries, compensation and benefits (total)
$2,590,343
Professional fundraising fees
$0
Accounting fees
$16,000
Occupancy
$12,221
Depreciation
$180,167
Program services (functional)
$3,189,546
Management and general (functional)
$790,648
Fundraising (functional)
$599,795

Balance sheet and other

Total assets, start of year
$7,559,145
Total assets, end of year
$8,297,238
Total liabilities, end of year
$1,467,942
Net assets, end of year
$6,829,296
Land, buildings and equipment
$543,411
Net assets without donor restrictions
$6,610,016
Net assets with donor restrictions
$219,280
Gross receipts
$6,203,837
Employees
18
Volunteers
20,323
Year formed
1990
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
MARILYN GRUNZWEIG GELLERCEO
Key employee
40$350,580$56,486
BRETT SPITALECHIEF OF STAFF
Key employee
40$223,440$33,831
VANESSA WEISBRODCHIEF EDUCATION & COMMUNIT
Key employee
40$186,408$42,507
BRADLEY HERREMABOARD SECRETARY
Trustee or director, Officer
2$0$0
JOHN WAGNERGOVERNMENT & ADVOCACY COMMITTEE CHAIR
Trustee or director, Officer
2$0$0
WARREN SAFTTREASURER
Trustee or director, Officer
2$0$0
ADRIENNE BENDERVICE CHAIR
Trustee or director, Officer
2$0$0
LEE JONESBOARD GOVERNANCE CO-CHAIR
Trustee or director
2$0$0
JAMIE RESINMEMBER
Trustee or director
2$0$0
BETH BLUEMEMBER
Trustee or director
2$0$0
DAN GIBBONSMEMBER
Trustee or director
2$0$0
KRISTIN YAREMAMEMBER
Trustee or director
2$0$0
GREG FRASCAMEMBER
Trustee or director
2$0$0
JORDAN RAMERBOARD GOVERNANCE CO-CHAIR
Trustee or director
2$0$0
JENNIFER SULLIVANMEMBER
Trustee or director
2$0$0
3 more people on this return
NameTitleHours / weekCompensation
BLAKELY BRANIFFDEVELOPMENT COMMITTEE CHAIR
Trustee or director
2$0
WILLIAM THURSTONBOARD CHAIR
Trustee or director, Officer
2$0
KAREN WICKERMEMBER
Trustee or director
2$0
990 for the year ended December 31, 2024: 16 people
NameTitleHours / weekCompensationOther / benefits
MARILYN GRUNZWEIG GELLERCEO
Key employee
40$335,685$19,851
BRETT SPITALECHIEF OF STAFF
Key employee
40$208,636$6,775
VANESSA WEISBRODCHIEF EDUCATION & COMMUNITY ENG. OFFICER
Key employee
40$185,611$8,120
BRADLEY HERREMABOARD SECRETARY
Trustee or director, Officer
2$0$0
JOHN WAGNERVICE CHAIR
Trustee or director, Officer
2$0$0
JORDAN RAMERTREASURER
Trustee or director, Officer
2$0$0
ADRIENNE BENDERBOARD CHAIR
Trustee or director, Officer
2$0$0
LEE JONESDEVELOPMENT COMMITTEE CHAI
Trustee or director
2$0$0
JAMIE RESINMEMBER
Trustee or director
2$0$0
WARREN SAFTMEMBER
Trustee or director
2$0$0
DAN GIBBONSMEMBER
Trustee or director
2$0$0
KRISTIN YAREMAMEMBER
Trustee or director
2$0$0
YASITH WEERASURIYAMEMBER
Trustee or director
2$0$0
CASEY GUBERMEMBER
Trustee or director
2$0$0
JENNIFER SULLIVANMEMBER
Trustee or director
2$0$0
BLAKELY BRANIFFMEMBER
Trustee or director
2$0$0
990 for the year ended December 31, 2023: 14 people
NameTitleHours / weekCompensationOther / benefits
MARILYN GRUNZWEIG GELLERCEO
Key employee
40$280,800$16,860
DEBORAH CEIZLERCDO
Key employee
40$205,271$3,500
BRADLEY HERREMABOARD SECRETARY
Trustee or director, Officer
2$0$0
JOHN WAGNERVICE CHAIR
Trustee or director, Officer
2$0$0
JORDAN RAMERTREASURER
Trustee or director, Officer
2$0$0
ADRIENNE BENDERBOARD CHAIR
Trustee or director, Officer
2$0$0
LEE JONESDEVELOPMENT COMMITTEE CHAIR
Trustee or director
2$0$0
JAMIE RESINMEMBER
Trustee or director
2$0$0
WARREN SAFTMEMBER
Trustee or director
2$0$0
DAN GIBBONSMEMBER
Trustee or director
2$0$0
KRISTIN YAREMAMEMBER
Trustee or director
2$0$0
YASITH WEERASURIYAMEMBER
Trustee or director
2$0$0
CASEY GUBERMEMBER
Trustee or director
2$0$0
WILLIAM THURSTONMEMBER
Trustee or director
2$0$0

Address and contacts

Address (IRS master file)
21300 VICTORY BLVD STE 300, WOODLAND HLS, CA 91367-7725
Principal officer (990 for 2025)
MARILYN GRUNZWEIG GELLER, 21300 VICTORY BLVD 300, WOODLAND HILLS, CA 91367
Signed the 990
MARILYN GRUNZWEIG GELLER, CEO
Phone
(818) 716-1513
Return prepared by
HENSIEK & CARON CPA'S

California records

California keeps its own records of charities and corporations. Search them by EIN 95-4310830 or by the name CELIAC DISEASE FOUNDATION.

Attorney General, Registry of Charities and Fundraisers
Registration status and filed reports (CT-TR-1, RRF-1)

Mission

THE CELIAC DISEASE FOUNDATION IS THE LEADING GLOBAL PATIENT ADVOCACY ORGANIZATION COMMITTED TO ACCELERATING DIAGNOSIS, TREATMENTS, AND A CURE FOR CELIAC DISEASE. OUR MISSION IS TO IMPROVE THE HEALTH AND WELL-BEING OF THE MILLIONS OF INDIVIDUALS AROUND THE WORLD AFFECTED BY THIS GENETIC AUTOIMMUNE DISEASE THROUGH OUR STRATEGIC INVESTMENTS IN RESEARCH, ADVOCACY, AND EDUCATION.

990 for the year ended December 31, 2025

Program accomplishments

  • RESEARCHTHE CELIAC DISEASE FOUNDATION MAKES STRATEGIC INVESTMENTS IN CUTTING-EDGE BIOMEDICAL RESEARCH AND COLLABORATES WITH RESEARCHERS AND CLINICIANS TO ADVANCE UNDERSTANDING OF AND TREATMENTS FOR CELIAC DISEASE. IN 2025, THE FOUNDATION AWARDED NEARLY $500,000 IN BREAKTHROUGH GRANTS FOCUSED ON IMMUNE RESPONSE TO GLUTEN AND DISEASE ONSET, FUNDING PROJECTS AT BOSTON CHILDREN'S HOSPITAL, UC DAVIS, COLORADO CHILDREN'S HOSPITAL, CHILDREN'S NATIONAL HOSPITAL, AND BETH ISRAEL DEACONESS MEDICAL CENTER. THE FOUNDATION SPONSORED MAJOR SCIENTIFIC GATHERINGS INCLUDING THE TAMPERE CELIAC DISEASE SYMPOSIUM, THE COLUMBIA UNIVERSITY CELIAC DISEASE ON THE HORIZON CONFERENCE, THE NASPGHAN SINGLE TOPIC SYMPOSIUM, AND THE COLORADO SCREENING SYMPOSIUM. IN A LANDMARK PARTNERSHIP, THE NORTH AMERICAN SOCIETY FOR THE STUDY OF CELIAC DISEASE (SSCD) BECAME THE FOUNDATION'S SCIENTIFIC ADVISORY COMMITTEE. THE FOUNDATION'S CLINICAL TRIAL RECRUITMENT PLATFORM, IQUALIFYCELIAC, SURPASSED 34,000 PARTICIPATING PATIENTS, WHILE IRECRUITCELIAC SUPPORTED 9 ACTIVE TRIALS ACROSS 9 NEW GLOBAL PARTNER ORGANIZATIONS ON 3 CONTINENTS. THE FOUNDATION ALSO LAUNCHED THE FIRST-EVER CELIAC DISEASE CLINICAL TRIAL SITE ADVISORY COUNCIL AND THE CELIAC DISEASE FOUNDATION IMPACT FUND, A VENTURE PHILANTHROPY VEHICLE TO FAST-TRACK BREAKTHROUGH THERAPIES AND DIAGNOSTICS FROM LAB TO PATIENT.________________________________________ADVOCACYIN 2025, THE CELIAC DISEASE FOUNDATION AFFIRMED ITS ROLE AS THE LEADING VOICE FOR CELIAC DISEASE POLICY. THE NIH ALLOCATED $10 MILLION FOR CELIAC DISEASE RESEARCH IN FY2025, AND CELIAC DISEASE WAS INCLUDED FOR THE THIRD CONSECUTIVE YEAR IN THE DEPARTMENT OF DEFENSE PEER REVIEWED MEDICAL RESEARCH PROGRAM, WITH $1.58 MILLION AWARDED. ADVOCATES FROM 14 STATES ATTENDED THE 2025 ADVOCACY SUMMIT AND HILL DAY, MEETING WITH 30 BIPARTISAN CONGRESSIONAL OFFICES AND SENDING MORE THAN 5,000 ADVOCACY EMAILS. ADVOCATES FROM ALL 50 STATES SUBMITTED CELIAC DISEASE AWARENESS MONTH PROCLAMATION REQUESTS, SECURING A RECORD 27 STATES AND WASHINGTON, D.C. CEO MARILYN G. GELLER REPRESENTED CELIAC PATIENTS AT THE 48TH SESSION OF THE CODEX COMMITTEE ON FOOD LABELLING IN QUEBEC CITY, SECURING AMENDED LABELING TEXT, INCLUSION OF CELIAC DISEASE IN MANDATORY PREPACKAGED FOOD LABELING AND PRECAUTIONARY ALLERGEN LABELING GUIDELINES, AND A CALL FOR EXPERTS TO INFORM SETTING A GLUTEN THRESHOLD. THE FOUNDATION ALSO CONVENED THE GLOBAL CELIAC ADVOCACY ALLIANCE, UNITING PATIENT ADVOCACY LEADERS FROM 12 ORGANIZATIONS ACROSS 6 CONTINENTS.________________________________________EDUCATIONTHE CELIAC DISEASE FOUNDATION PROVIDES INNOVATIVE TOOLS AND PROGRAMMING TO PROMOTE CELIAC DISEASE EDUCATION FOR PATIENTS, FAMILIES, AND HEALTHCARE PROFESSIONALS. THROUGH CELIAC.ORG, THE FOUNDATION OFFERS A SYMPTOMS ASSESSMENT TOOL, A NATIONWIDE PRACTITIONER DIRECTORY, EAT! GLUTEN-FREE MEAL PLANS, AND THE CELIAC DISEASE MANAGEMENT PLAN FOR SCHOOL TRAINING PROGRAM. VIRTUAL PROGRAMMING - INCLUDING CULINARY MEDICINE WEBINARS NOW AVAILABLE WITH LIVE SPANISH AND PORTUGUESE TRANSLATION - REACHED OVER 1,000 PATIENTS AND 200 HEALTHCARE PROFESSIONALS IN 2025. THE FOUNDATION CONVENED THE COLLEGE CONSENSUS SUMMIT TO DEVELOP THE FIRST-EVER NATIONAL RECOMMENDATIONS FOR SUPPORTING COLLEGE STUDENTS WITH CELIAC DISEASE, AND LAUNCHED THE CELIAC DISEASE FOUNDATION DIETITIAN ADVISORY COUNCIL. TOOLS FOR HEALTHCARE PROFESSIONALS INCLUDE THE NASPGHAN CLINICAL GUIDE FOR PEDIATRIC CELIAC DISEASE, THE CELIAC DISEASE AND PSYCHOLOGICAL HEALTH TRAINING PROGRAM, AND ACCREDITED CME/CEU PROGRAMS. THE FOUNDATION REACHES A GLOBAL AUDIENCE THROUGH CELIAC.ORG, SOCIAL MEDIA CHANNELS WITH OVER 250,000 FOLLOWERS AND 25 MILLION VIEWS, AND AN E-NEWSLETTER WITH MORE THAN 100,000 SUBSCRIBERS.
    Expenses $3,189,546 · grants $355,540 · revenue $2,386,650

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
95-4310830
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1995
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$8,297,238
Income (IRS master file)
$6,203,837

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$5,315,881$4,579,989$8,297,238XML
990December 2024$4,294,353$4,336,074$7,559,145XML
990December 2023$4,203,443$2,975,235$5,959,854XML
990December 2022$3,118,626$2,177,592$4,468,403IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 95-4310830).

Questions about CELIAC DISEASE FOUNDATION

What is the EIN of CELIAC DISEASE FOUNDATION?
The employer identification number (EIN) of CELIAC DISEASE FOUNDATION is 95-4310830.
Is CELIAC DISEASE FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1995.
Are donations to CELIAC DISEASE FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does CELIAC DISEASE FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of CELIAC DISEASE FOUNDATION due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CELIAC DISEASE FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of CELIAC DISEASE FOUNDATION?
The 990 for the year ended December 31, 2025 names MARILYN GRUNZWEIG GELLER.
Who are the officers and directors of CELIAC DISEASE FOUNDATION?
The 990 for the year ended December 31, 2025 lists 18 people; 3 received compensation from the organization, the highest $350,580 (MARILYN GRUNZWEIG GELLER, CEO).
How much revenue does CELIAC DISEASE FOUNDATION have?
On its 990 for the year ended December 31, 2025 it reported revenue of $5,315,881, expenses of $4,579,989 and total assets of $8,297,238 at year end.

Other nonprofits in WOODLAND HLS

All nonprofits in WOODLAND HLS · California · Voluntary health associations and medical disciplines